As the first AstraZeneca shots arrive in South America via the WHO’s Covax program, the international public-health agency has promised to investigate reports that the vaccine may be linked to dangerous blood clots.
Yesterday, Europe’s already struggling COVID vaccine rollout took another hit when more than half a dozen nations stopped doling out COVID vaccines created by AstraZeneca following reports that some patients who received the vaccine developed life-threatening lung clots, with at least one person having subsequently died as a result.
While health authorities in Denmark, one of the first countries to halt the AstraZeneca-Oxford jab, said it was impossible to tell if there was any connection, the spate of suspicious cases is apparently enough to prompt health authorities to take a closer look. On Friday morning, Thailand became the first non-European country to halt the AstraZeneca vaccine, while several other nations, including Canada, Australia, the Philippines and South Korea, have all said they would move forward.
Bulgaria became the latest European nation to suspend the vaccine on Friday. According to Reuters, the Bulgarian government wants the EMA to send over a written statement outlining its argument about why it should allow vaccinations to go forward.
The news has put pressure on shares of AstraZeneca, which on Friday added to their declines from earlier in the week.
Norway’s top medical regulators confirmed Friday that they had received reports of a death in a patient who had received the vaccine in the county of Innland, according to a statement by NIPH.
Read more at Zero Hedge